comparemela.com

Latest Breaking News On - Diabetes drugs - Page 8 : comparemela.com

Embecta Shares Fall Despite Outlook Raise, Strong 1Q

By Dean Seal Shares of Embecta fell despite the company raising its full-year outlook and recording better-than-expected results in its fiscal first quarter..

Dean-seal
Article-normal
Pharmaceuticals
Healthcare-life-sciences
Specialized-drugs-medications
Hormone-products
Diabetes-drugs
Financial-performance
Share-price-movement-disruptions
Corporate-industrial-news
Equity-markets

Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook

U.S. prices for Lilly’s drugs climbed 27%, driven by diabetes treatment Mounjaro, while prices outside the U.S. fell.

Eli-lilly
Article-normal
Weightloss
Diabetes
Pharmaceuticals
Machinery
Agricultural-machinery
Health-care
Specialized-drugs-medications
Hormone-products
Industrial-goods

Pharma companies raise prices on over 900 drugs amid 'historic' negotiations

Drug companies raised prices on 910 name-brand drugs in January. The median price increase was 4.7%, the lowest increase in over a decade.

Italy
United-states
American
America
Americans
Italian
Antonio-ciaccia
Xavier-becerra
Hill-dermaceuticals
Leigh-purvis
Eli-lilly-mounjaro
Eli-lilly-co

NC State Health Plan is ending coverage of weight-loss drugs. What members need to know

Here are answers to frequently asked questions about changes to the NC State Health Plan’s coverage of weight-loss drugs like Wegovy and Saxenda.

Michigan
United-states
Connecticut
Novo-nordisk
Nicole-ferreira
Frank-lester
University-of-michigan
Health-plan
University-of-texas
Nc-state-health-plan
State-health-plan
Deputy-treasurer-frank

China Diabetes Care Drugs Market to Reach USD 13.73 Billion

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) The

Dublin
Ireland
China
Chinese
Novo-nordisk
Eli-lilly
Novartis
Astrazeneca
Sanofi-aventis
Boehringer-ingelheim
Bristol-myers-squibb
Pfizer

vimarsana © 2020. All Rights Reserved.